Stock listing
Lakewood-amedex Biotherapeutics Inc.
Selected listing: LABT · NASDAQ · USD · US
Lakewood-amedex Biotherapeutics Inc. (NASDAQ:LABT), Health Technology. Latest release Oct 1, 2026: Lakewood-Amedex Biotherapeutics Announces Participation…
- Ticker
- NASDAQ:LABT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Lakewood-amedex Biotherapeutics Inc.
Lakewood-amedex Biotherapeutics Inc. (ticker: LABT) is a public company based in the United States, focused on biotherapeutics. Lakewood-amedex aims to address unmet medical needs through its research and product development efforts.
Latest news from Lakewood-amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences
October 1, 2026
Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences
September 30, 2026
Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers
September 28, 2026
Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3
September 21, 2026
Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot Ulcers
September 18, 2026
Research Lakewood-amedex Biotherapeutics Inc.
Lakewood-amedex Biotherapeutics Inc. company profile
View the public company page for Lakewood-amedex Biotherapeutics Inc. on 6ix.
Lakewood-amedex Biotherapeutics Inc. news
Read company news and market updates connected to Lakewood-amedex Biotherapeutics Inc..
Lakewood-amedex Biotherapeutics Inc. investor events
Find investor webinars, events, and replay context for Lakewood-amedex Biotherapeutics Inc..